NASDAQ:CRON Cronos Group (CRON) Stock Price, News & Analysis $1.92 -0.01 (-0.26%) As of 12:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Cronos Group Stock (NASDAQ:CRON) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cronos Group alerts:Sign Up Key Stats Today's Range$1.91▼$1.9450-Day Range$1.68▼$2.1452-Week Range$1.60▼$2.54Volume248,466 shsAverage Volume1.34 million shsMarket Capitalization$742.44 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.Read More… Cronos Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks36th Percentile Overall ScoreCRON MarketRank™: Cronos Group scored higher than 36% of companies evaluated by MarketBeat, and ranked 1625th out of 1,876 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Cronos Group. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Cronos Group are expected to grow in the coming year, from ($0.03) to $0.03 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cronos Group is -14.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cronos Group is -14.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioCronos Group has a PEG Ratio of 1.74. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCronos Group has a P/B Ratio of 0.67. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Cronos Group's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.66% of the float of Cronos Group has been sold short.Short Interest Ratio / Days to CoverCronos Group has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cronos Group has recently decreased by 7.56%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCronos Group does not currently pay a dividend.Dividend GrowthCronos Group does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.66% of the float of Cronos Group has been sold short.Short Interest Ratio / Days to CoverCronos Group has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cronos Group has recently decreased by 7.56%, indicating that investor sentiment is improving significantly. News and Social Media3.6 / 5News SentimentN/A News SentimentCronos Group has a news sentiment score of 1.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Cronos Group this week, compared to 2 articles on an average week.Search Interest5 people have searched for CRON on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.MarketBeat Follows4 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cronos Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 7.30% of the stock of Cronos Group is held by insiders.Percentage Held by InstitutionsOnly 8.71% of the stock of Cronos Group is held by institutions.Read more about Cronos Group's insider trading history. Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CRON Stock News HeadlinesCronos Group And 2 Other Noteworthy Penny Stocks On The TSXJune 9, 2025 | finance.yahoo.comCronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer ConferenceJune 2, 2025 | globenewswire.comThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.June 17, 2025 | Brownstone Research (Ad)Cronos Group: Industry Fortress Balance Sheet And FCF Create A Solid Upside PotentialMay 22, 2025 | seekingalpha.comCronos Reports Improved Financials For Q1-2025 As Demand Outpaces SupplyMay 17, 2025 | seekingalpha.comShareholders Can Be Confident That Cronos Group's (TSE:CRON) Earnings Are High QualityMay 16, 2025 | finance.yahoo.comCronos Group Inc. (NASDAQ:CRON) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comCronos Group Inc. (CRON) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comSee More Headlines CRON Stock Analysis - Frequently Asked Questions How have CRON shares performed this year? Cronos Group's stock was trading at $2.02 at the beginning of 2025. Since then, CRON stock has decreased by 4.7% and is now trading at $1.9250. View the best growth stocks for 2025 here. How were Cronos Group's earnings last quarter? Cronos Group Inc. (NASDAQ:CRON) posted its quarterly earnings results on Thursday, May, 8th. The company reported $0.02 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.01. The company had revenue of $33.62 million for the quarter, compared to analysts' expectations of $45.44 million. Cronos Group had a negative trailing twelve-month return on equity of 2.56% and a negative net margin of 42.65%. Read the conference call transcript. Who are Cronos Group's major shareholders? Top institutional investors of Cronos Group include MMCAP International Inc. SPC (0.46%), Goldman Sachs Group Inc. (0.28%), SeaCrest Wealth Management LLC (0.08%) and Formidable Asset Management LLC (0.07%). View institutional ownership trends. How do I buy shares of Cronos Group? Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings5/08/2025Today6/17/2025Next Earnings (Estimated)8/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:CRON CIK1656472 Webwww.thecronosgroup.com Phone(416) 504-0004FaxN/AEmployees450Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.13 Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth1.74Net Income-$73.96 million Net Margins-42.65% Pretax Margin-49.33% Return on Equity-2.56% Return on Assets-2.47% Debt Debt-to-Equity RatioN/A Current Ratio24.24 Quick Ratio23.05 Sales & Book Value Annual Sales$124.59 million Price / Sales5.97 Cash FlowN/A Price / Cash FlowN/A Book Value$2.87 per share Price / Book0.67Miscellaneous Outstanding Shares385,682,000Free Float356,136,000Market Cap$744.37 million OptionableOptionable Beta1.04 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (NASDAQ:CRON) was last updated on 6/17/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.